Skip to main content

Table 4 Quality evaluation by Drummond checklist

From: Cost-effectiveness of immunotherapies for advanced squamous non-small cell lung cancer: a systematic review

Drummond Checklist/Study Authors

Was a Well-Defined Question Posed in an Answerable Form?

Was a Comprehensive Description of

the Competing Alternatives Given?

Was the Effectiveness of the Program Established?

Were All the Important and Relevant

Costs and Consequences for Each

Alternative Identified?

Were Costs and Consequences

Measured Accurately in Appropriate

Physical Units?

Were Costs and Consequences Valued

Credibly?

Were Costs and Consequences

Adjusted for Differential Timing?

Was an Incremental Analysis of Costs

and Consequences of Alternatives

Performed?

Was Allowance Made for Uncertainty

in the Estimates of Costs and

Consequences?

Did the Presentation and Discussion

of Study Results Include All Issues of

Concern to Users?

Total

Chaudhary (2021)

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

10

Gao (2018)

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

10

Goeree (2016)

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

10

Hu (2023)

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

10

Insinga (2019)

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

10

Chen (2022)

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

10

Cheng (2022)

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

10

Chouaid (2019)

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

10

Liu (2022)

Yes

Yes

Yes

Yes

Yes

Yes

No

Yes

Yes

Yes

9

Rothwell (2021)

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

10

Shao (2022)

Yes

Yes

Yes

Yes

Yes

Yes

No

Yes

Yes

Yes

9

Zhang (2023)

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

10

Zhao (2023)

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

10

Zhou (2023)

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

10

Li (2022)

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

10